NTLA Intellia Therapeutics, Inc.
$10.96▲ +1.44%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.53B
P/E Ratio
–
Div Yield
–%
52W Range
7.95 - 28.25
% vs 50 MA
-21.05%
% vs 200 MA
-18.04%
RSI-14
32.5
MACD Histogram
-0.3500
Beta (1Y vs SPY)
2.31
Gross Rev
$66.09M
Gross Profit
-$230.67M
EBITDA
-$411.24M
COGS
$296.76M
Operating Exp
$180.57M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.66 · 28 posts
NewsDiscussionWhat if the next AI is genetics?
r/StockMarket · Jun 2, 2026
The post highlights NTLA's role in gene-editing therapies, indicating a positive view.
positive
+0.60
NewsDiscussionWhat if the next AI is genetics?
r/stocks · Jun 2, 2026
Highlights NTLA's focus on gene editing, aligning with the post's theme.
positive
+0.70
DiscussionDDTradeBack to picks?
r/wallstreetbets · May 9, 2026
NTLA is described as an 'asymmetric play' with a 'short term acquisition narrative', indicating a positive outlook.
positive
+0.70
NewsDD$NTLA short squeze, viable or not
r/wallstreetbets · Jan 27, 2026
The post expresses optimism due to the short squeeze and FDA approval, suggesting a potential upward trend for the stock.
positive
+0.60
DDNewsDiscussionIntellia, NTLA, highest shorted stock on Wall Street with breakthrough gene editing technology
r/wallstreetbets · Jan 13, 2026
The post expresses optimism about the stock's future following the FDA hold lift and trial resumption.
positive
+0.70
Page 1 of 6 (28 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.